Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

September 29, 2020
Open Access

Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody

Drug Design, Development and Therapy
Lei HuangJianmin Fang
January 15, 2021

BNCT for primary synovial sarcoma.

Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
Takuya FujimotoTakanori Hirose
January 7, 2021
Open Access

The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates

BMC Cancer
Antonella VecchiatoClinical National Melanoma Registry Study Group at the Italian Melanoma Intergroup (IMI)
July 16, 2020
Open Access

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas

Varun MongaMohammed Milhem
January 4, 2021

Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype

Annals of Surgical Oncology
Audree B TadrosGeorge Plitas
November 20, 2020

Predicting Postoperative Mortality After Metastatic Intraspinal Neoplasm Excision: Development of a Machine-Learning Approach

World Neurosurgery
Kevin J DiSilvestroAlan H Daniels
September 13, 2020

Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study

Cancer Immunology, Immunotherapy : CII
Asmaa M ZahranAmal Rayan
August 17, 2020
Open Access

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Wassim AbidaTRITON2 investigators
November 24, 2020
Open Access

Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Stefan DietzschRolf-Dieter Kortmann
January 13, 2021
Open Access

Clinicopathologic features of single bone metastasis in breast cancer

Murat KaratasAdam Uslu
October 17, 2020
Open Access

Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients

Pilot and Feasibility Studies
Hans Van HulleLiv Veldeman
December 10, 2020
Open Access

Diagnostic performance of EBUS-TBNA and its interrelation with PET-CT in patients with extra-thoracic malignancies

Tüberküloz ve toraks
Ezgi DemirdöğenMehmet Karadağ
December 1, 2020

Local Control Following Proton Therapy for Pediatric Chordoma

International Journal of Radiation Oncology, Biology, Physics
Daniel J IndelicatoJulie A Bradley
December 17, 2020

Detecting lymph node metastasis of esophageal cancer on dual-energy computed tomography

Acta Radiologica
Xuyang SunJun Hashimoto
August 29, 2020

Executive Summary of the American Radium SocietyTM (ARS) Appropriate Use Criteria (AUC) for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines

International Journal of Radiation Oncology, Biology, Physics
Christopher J AnkerSalma K Jabbour

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensor Development & Applications

Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

© 2021 Meta ULC. All rights reserved